Freeman Robert Thomas

SEC source: 0001209191-22-018003 · doc4.xml · derivative · entry 3

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,365

Underlying: Common Stock · 100,365 shares

Expires 2032-03-08

F3 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001209191-22-018003 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,505

F1 · kind: Represents 136,589 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company.

SEC source: 0000950142-21-003812 · es210205301_4-freeman.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 731,939

F1 · kind: Represents 85,279 shares of Common Stock sold pursuant to a registered offering which closed on November 23, 2021, at a price of $20.1075 (net of underwriting discount).

F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0001209191-21-061404 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 817,218

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported price in column 4 is a weighted average price. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4.

F2 · price: The shares were sold in multiple transactions at prices ranging from $19.26 to $19.51 per share.

F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 4

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 885,645

F6 · kind: Represents 38,919 shares of Common Stock sold pursuant to the partial exercise by the underwriters of their over-allotment option after the closing of the Company's initial public offering, at a price of $16.83 (net of underwriting discount).

F5 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · nonDerivative · entry 3

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 840,218

F4 · kind: Represents 38,919 shares of Common Stock sold pursuant to the partial exercise by the underwriters of their over-allotment option after the closing of the Company's initial public offering, at a price of $16.83 (net of underwriting discount).

F5 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000899243-21-015446 · doc4.xml · derivative · entry 6

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 572,040

Underlying: Common Stock · 572,040 shares

Expires 2031-03-25

F9 · kind: Represents 572,042 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F8 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

F5 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000899243-21-015446 · doc4.xml · derivative · entry 5

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,680

Underlying: Common Stock · 190,680 shares

Expires 2031-03-25

F7 · kind: Represents 190,680 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F8 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 3

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 924,564

F4 · kind: Represents 45,427 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F5 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,489

F3 · kind: Represents 15,142 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,347

F1 · kind: Represents 38,060 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 19,030 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Freeman's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, and (Continued in Footnote 2)

F2 · kind: (Continued From Footnote 1) (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule applicable to Mr. Freeman disclosed in the "Executive Compensation - Outstanding Equity Awards at Fiscal Year End" section of the Company's registration statement on Form S-1. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · derivative · entry 4

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 762,720

Underlying: Common Stock · 762,720 shares

Expires 2031-03-25

F6 · kind: Represents 762,720 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F7 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,916

F3 · kind: Represents 60,569 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,347

F1 · kind: Represents 38,060 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 19,030 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Freeman's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, and (Continued in Footnote 2)

F2 · kind: (Continued From Footnote 1) (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule applicable to Mr. Freeman disclosed in the "Executive Compensation - Outstanding Equity Awards at Fiscal Year End" section of the Company's registration statement on Form S-1. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.